Legend Biotech's CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
China Universal Asset Management Co. Ltd. boosted its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 350.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,222 shares of the company’s stock after purchasing an additional 7,174 […]
China Universal Asset Management Co. Ltd. boosted its stake in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 350.3% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 9,222 shares of the company’s stock after buying an additional 7,174 shares during the quarter. China Universal Asset Management Co. Ltd.’s holdings in Legend […]
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
The United States leads the pack in the food color market, boasting a steady CAGR of 5.6%, surpassing growth rates in other countries. This growth can be.